DR. IRENE KAZHDAN, M.D.
Osteopathic Medicine at Medical Dr, San Antonio, TX

License number
Texas M0776
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address 2
4411 Medical Dr SUITE 100, San Antonio, TX 78229
PO Box 911230, Dallas, TX 75391
Phone
(210) 595-5300
(210) 595-5301 (Fax)
(972) 994-5411
(972) 234-2987 (Fax)

Organization information

See more information about IRENE KAZHDAN at bizstanding.com

Irene Kazhdan MD

7979 Wurzbach Rd, San Antonio, TX 78229

Industry:
Internist
Phone:
(210) 450-3833 (Phone), (210) 450-1270 (Phone)
Irene Kazhdan
Categories:
Oncology Physicians & Surgeons, Physicians & Surgeons


Cancer Care Ctr-South Texas - Irene Kazhdan MD

4411 Medical Dr STE 100, San Antonio, TX 78229

Categories:
Cardiology Physicians & Surgeons
Phone:
(210) 595-5300 (Phone)


University Of TX HSC San Anton - Irene Kazhdan MD

7703 Floyd Curl Dr #719L, San Antonio, TX 78229

Categories:
Electronic Commerce, Oncology Physicians & Surgeons
Phone:
(210) 567-7000 (Phone)

Professional information

Irene Kazhdan Photo 1

Dr. Irene Kazhdan, San Antonio TX - MD (Doctor of Medicine)

Specialties:
Oncology, Medical Oncology
Address:
Canthera Cancer Therapy Center
1314 E Sonterra Blvd STE 5101, San Antonio 78258
(210) 404-0044 (Phone)
Certifications:
Internal Medicine, 2009, Medical Oncology, 2013
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Canthera Cancer Therapy Center
1314 E Sonterra Blvd STE 5101, San Antonio 78258
Methodist Stone Oak Hospital
1139 East Sonterra Blvd, San Antonio 78258
Education:
Medical School
1st Pavlov S Leningrad Med Insti
Pennsylvania Hospital Of The University Of Pa Health System
Graduated: 1997
Graduated: 1999
University Of Texas Health Center
Graduated: 2002


Irene Kazhdan Photo 2

Irene Kazhdan, San Antonio TX

Specialties:
Oncologist
Address:
4411 Medical Dr, San Antonio, TX 78229
1314 E Sonterra Blvd, San Antonio, TX 78258
Education:
Doctor of Medicine
University Health System - Fellowship - Oncology (Internal Medicine)
Hospital of the University of Pennsylvania - Residency - Internal Medicine
Hospital of the University of Pennsylvania - Internship - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)


Irene Kazhdan Photo 3

Irene Kazhdan, San Antonio TX

Specialties:
Internal Medicine, Hematology, Medical Oncology
Work:
Cancer Care Ctrs. Of South Texas
4411 Medical Dr, San Antonio, TX 78229 Boerne
124 E Bandera Rd, Boerne, TX 78006
Education:
First Leningrad I P Pavlov Medical Institute (1981)


Irene Kazhdan Photo 4

Multifunctional Core For Molecular Imaging And Targeted Delivery Of Macromolecules And Drugs

US Patent:
2007012, Jun 7, 2007
Filed:
Jul 27, 2006
Appl. No.:
11/460500
Inventors:
Zheng Wang - San Antonio TX, US
Irene Kazhdan - San Antonio TX, US
Jian Gao - Helotes TX, US
Zhiqiang Han - San Antonio MO, US
Robert Marciniak - San Antonio TX, US
International Classification:
A61K 49/00, A61K 48/00, A61K 31/409, A61K 31/555
US Classification:
424009600, 514044000, 424009610, 514185000, 514410000
Abstract:
In the broadest sense an inventive conjugate includes a macrocyclic scaffold moiety incorporating at least one nitrogen atom. Through linkages to the ring, nitrogen atoms are bonded to at least one therapeutic species, or one cellular trafficking species, and preferably two or more types of trafficking species. The linkages between ring nitrogen atoms and agents are formed through N—C, N—S, N—O or N—N bonds. It is appreciated that more than one agent or agent species are coupled to a ring nitrogen atom through the inclusion of a branched carbon atom or secondary amine nitrogen within the intermediate between the agent and ring nitrogen atom. A disulfide bond intermediate between an agent and a linkage to the ring nitrogen is preferred in instances where intracellular release of the agent or trafficking species is desired. An optional metal ion is coordinated by the scaffolding moiety.


Irene Kazhdan Photo 5

Compositions And Methods For Modulation Of Pdx-1

US Patent:
2009016, Jun 25, 2009
Filed:
Feb 14, 2008
Appl. No.:
12/031139
Inventors:
Irene Kazhdan - San Antonio TX, US
Zhiqiang Han - Fenton MO, US
Zheng Jim Wang - San Antonio TX, US
Ting-Tung Chang - San Antonio TX, US
Robert A. Marciniak - San Antonio TX, US
Assignee:
Ontherex LLC - San Antonio TX
International Classification:
A61K 31/7088, C12N 5/06, C12N 15/00
US Classification:
514 44, 435375, 4353201
Abstract:
Methods and compositions for inhibiting PDX-1 are provided according to the present invention. An anti-PDX-1 agent included in inventive methods and compositions includes an antibody, an aptamer, an antisense oligonucleotide, a ribozyme and/or an inhibitory compound. Methods of inhibiting PDX-1 expression in a tumor cell are provided by the present invention which include contacting a tumor cell with an effective amount of an anti-PDX- agent highly or completely complementary to a specified region of an RNA molecule encoding PDX-1. Such an agent specifically hybridizes with the RNA molecule encoding PDX-1 and inhibits the expression of a PDX-1 gene in the tumor cell. Compositions including anti-PDX-1 siRNA and/or shRNA are described. Recombinant expression constructs encoding anti-PDX-1 siRNA or shRNA according to the present invention are described.


Irene Kazhdan Photo 6

Methods And Compositions For Combinatorial Approaches To Cancer Gene Therapy

US Patent:
2008010, May 8, 2008
Filed:
Oct 27, 2004
Appl. No.:
10/578445
Inventors:
Irene Kazhdan - San Antonio TX, US
International Classification:
A61K 31/7088, C07H 21/00, C12N 15/63, A61P 35/00, C12N 15/64
US Classification:
514 44, 536 231, 4353201
Abstract:
The present invention provides a nucleic acid comprising a) a nucleotide sequence encoding one or more pro-apoptotic proteins, and b) a nucleotide sequence encoding one or more tumor-specific and/or tissue-specific promoters. Also provided is a method of treating cancer, comprising administering the compositions of this invention to a subject.